Yonghong Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yonghong Peng has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Baoyan Liu
China Academy Of Chinese Medical Sciences
1 shared publication Bin Yao
Department of Electronic Imaging and Media Communications, University of Bradford, West Yorkshire BD7 1DP, UK
1 shared publicationCaiyan Jia
School of Computer and Information Technology and Beijing Key Lab of Traffic Data Analysis and Mining, Beijing Jiaotong University, Beijing 100044, China
1 shared publication- Changkai Sun
Liaoning Provincial Key Laboratory of Cerebral Diseases, Institute for Brain Disorders, Dalian Medical University, Dalian 116044, China
1 shared publication - Desmond John Tobin
Charles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland
1 shared publication Jian Yu
School of Computer and Information Technology and Beijing Key Lab of Traffic Data Analysis and Mining, Beijing Jiaotong University, Beijing 100044, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-10
Network Based Integrated Analysis of Phenotype-Genotype Data for Prioritization of Candidate Symptom Genes
Background. Symptoms and signs (symptoms in brief) are the essential clinical manifestations for individualized diagnosis and treatment in traditional Chinese medicine (TCM). To gain insights into the molecular mechanism of symptoms, we develop a computational approach to identify the candidate genes of symptoms.Methods. This paper presents a network-based approach for the integrated analysis of multiple phenotype-genotype data sources and the prediction of the prioritizing genes for the associated symptoms. The method first calculates the similarities between symptoms and diseases based on the symptom-disease relationships retrieved from the PubMed bibliographic database. Then the disease-gene associations and protein-protein interactions are utilized to construct a phenotype-genotype network. The PRINCE algorithm is finally used to rank the potential genes for the associated symptoms.Results. The proposed method gets reliable gene rank list with AUC (area under curve) 0.616 in classification. Some novel genes like CALCA, ESR1, and MTHFR were predicted to be associated with headache symptoms, which are not recorded in the benchmark data set, but have been reported in recent published literatures.Conclusions. Our study demonstrated that by integrating phenotype-genotype relationships into a complex network framework it provides an effective approach to identify candidate genes of symptoms.
- 1 January 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-10
Open AccessNetwork Based Integrated Analysis of Phenotype-Genotype Data for Prioritization of Candidate Symptom Genes
Background. Symptoms and signs (symptoms in brief) are the essential clinical manifestations for individualized diagnosis and treatment in traditional Chinese medicine (TCM). To gain insights into the molecular mechanism of symptoms, we develop a computational approach to identify the candidate genes of symptoms.Methods. This paper presents a network-based approach for the integrated analysis of multiple phenotype-genotype data sources and the prediction of the prioritizing genes for the associated symptoms. The method first calculates the similarities between symptoms and diseases based on the symptom-disease relationships retrieved from the PubMed bibliographic database. Then the disease-gene associations and protein-protein interactions are utilized to construct a phenotype-genotype network. The PRINCE algorithm is finally used to rank the potential genes for the associated symptoms.Results. The proposed method gets reliable gene rank list with AUC (area under curve) 0.616 in classification. Some novel genes like CALCA, ESR1, and MTHFR were predicted to be associated with headache symptoms, which are not recorded in the benchmark data set, but have been reported in recent published literatures.Conclusions. Our study demonstrated that by integrating phenotype-genotype relationships into a complex network framework it provides an effective approach to identify candidate genes of symptoms.
- 1 July 2013
- Published by Elsevier in Computers and Electrical Engineering
- Vol. 39 (5) , 1461-1463
Introduction to the special issue on Recent advance in signal processing, biomedical engineering and informatics
- 1 July 2013
- Published by Elsevier in Computers and Electrical Engineering
- Vol. 39 (5) , 1461-1463
Introduction to the special issue on Recent advance in signal processing, biomedical engineering and informatics
- Open Access
A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis
Genome-wide microarray technology has facilitated the systematic discovery of diagnostic biomarkers of cancers and other pathologies. However, meta-analyses of published arrays often uncover significant inconsistencies that hinder advances in clinical practice. Here we present an integrated microarray analysis framework, based on a genome-wide relative significance (GWRS) and genome-wide global significance (GWGS) model. When applied to five microarray datasets on melanoma published between 2000 and 2011, this method revealed a new signature of 200 genes. When these were linked to so-called ‘melanoma driver’ genes involved in MAPK, Ca2+, and WNT signaling pathways we were able to produce a new 12-gene diagnostic biomarker signature for melanoma (i.e., EGFR, FGFR2, FGFR3, IL8, PTPRF, TNC, CXCL13, COL11A1, CHP2, SHC4, PPP2R2C, and WNT4). We have begun to experimentally validate a subset of these genes involved in MAPK signaling at the protein level, including CXCL13, COL11A1, PTPRF and SHC4 and found these to be over-expressed in metastatic and primary melanoma cells in vitro and in situ compared to melanocytes cultured from healthy skin epidermis and normal healthy human skin. While SHC4 has been reported previously to be associated to melanoma, this is the first time CXCL13, COL11A1, and PTPRF have been associated with melanoma on experimental validation. Our computational evaluation indicates that this 12-gene biomarker signature achieves excellent diagnostic power in distinguishing metastatic melanoma from normal skin and benign nevus. Further experimental validation of the role of these 12 genes in a new signaling network may provide new insights into the underlying biological mechanisms driving the progression of melanoma.
Open AccessA new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis
Genome-wide microarray technology has facilitated the systematic discovery of diagnostic biomarkers of cancers and other pathologies. However, meta-analyses of published arrays often uncover significant inconsistencies that hinder advances in clinical practice. Here we present an integrated microarray analysis framework, based on a genome-wide relative significance (GWRS) and genome-wide global significance (GWGS) model. When applied to five microarray datasets on melanoma published between 2000 and 2011, this method revealed a new signature of 200 genes. When these were linked to so-called ‘melanoma driver’ genes involved in MAPK, Ca2+, and WNT signaling pathways we were able to produce a new 12-gene diagnostic biomarker signature for melanoma (i.e., EGFR, FGFR2, FGFR3, IL8, PTPRF, TNC, CXCL13, COL11A1, CHP2, SHC4, PPP2R2C, and WNT4). We have begun to experimentally validate a subset of these genes involved in MAPK signaling at the protein level, including CXCL13, COL11A1, PTPRF and SHC4 and found these to be over-expressed in metastatic and primary melanoma cells in vitro and in situ compared to melanocytes cultured from healthy skin epidermis and normal healthy human skin. While SHC4 has been reported previously to be associated to melanoma, this is the first time CXCL13, COL11A1, and PTPRF have been associated with melanoma on experimental validation. Our computational evaluation indicates that this 12-gene biomarker signature achieves excellent diagnostic power in distinguishing metastatic melanoma from normal skin and benign nevus. Further experimental validation of the role of these 12 genes in a new signaling network may provide new insights into the underlying biological mechanisms driving the progression of melanoma.
- 20 September 2007
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 41 (2) , 83-86
Integrative data mining in systems biology: from text to network mining
- 20 September 2007
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 41 (2) , 83-86
Integrative data mining in systems biology: from text to network mining
- 20 October 2006
- Published by Taylor & Francis in International Journal of Systems Science
- Vol. 37 (13) , 931-938
Integration of gene functional diversity for effective cancer detection
DNA microarray technology has demonstrated to be an effective methodology for the diagnosis of diseases and cancers by means of expression data classification. Although much research has been conducted during the recent years to apply machine learning techniques for microarray data classification, there are two important issues that prevent the use of conventional machine learning techniques, namely the limited availability of training samples and the existence of various uncertainties. This article presents an integrative classification system, based on the ensemble of machine learning, to integrate the diverse functions of multiple groups of genes in order to achieve a robust microarray data classification. Ensemble learning combines a set of base classifiers as a committee to make more appropriate decisions when classifying new data instances. In order to enhance the performance of the ensemble learning process, the approach presented includes a procedure to select optimal ensemble members based on their classification behaviour. The proposed approach has been verified by three microarray data sets for cancer detection. Experimental results showed that the performance of cancer detection can be much improved by integrating a different subgroup of genes, which suggests, instead of seeking individual gene makers, that a robust cancer detection system can be developed based on integration of related gene groups with diverse functions.
- 20 October 2006
- Published by Taylor & Francis in International Journal of Systems Science
- Vol. 37 (13) , 931-938
Integration of gene functional diversity for effective cancer detection
DNA microarray technology has demonstrated to be an effective methodology for the diagnosis of diseases and cancers by means of expression data classification. Although much research has been conducted during the recent years to apply machine learning techniques for microarray data classification, there are two important issues that prevent the use of conventional machine learning techniques, namely the limited availability of training samples and the existence of various uncertainties. This article presents an integrative classification system, based on the ensemble of machine learning, to integrate the diverse functions of multiple groups of genes in order to achieve a robust microarray data classification. Ensemble learning combines a set of base classifiers as a committee to make more appropriate decisions when classifying new data instances. In order to enhance the performance of the ensemble learning process, the approach presented includes a procedure to select optimal ensemble members based on their classification behaviour. The proposed approach has been verified by three microarray data sets for cancer detection. Experimental results showed that the performance of cancer detection can be much improved by integrating a different subgroup of genes, which suggests, instead of seeking individual gene makers, that a robust cancer detection system can be developed based on integration of related gene groups with diverse functions.
- 1 June 2006
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 36 (6) , 553-573
A novel ensemble machine learning for robust microarray data classification
- 1 June 2006
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 36 (6) , 553-573
A novel ensemble machine learning for robust microarray data classification
- 31 May 2006
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 37 (1) , 43-53
Knowledge-discovery incorporated evolutionary search for microcalcification detection in breast cancer diagnosis
- 31 May 2006
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 37 (1) , 43-53
Knowledge-discovery incorporated evolutionary search for microcalcification detection in breast cancer diagnosis
- 1 January 2006
- Published by Springer Nature
- Vol. 25 (5) , 347-354
Detection of Microcalcifications in Digital Mammograms Based on Dual-Threshold
Breast cancer is one of the main leading causes to women mortality in the world especially in the western countries. Since the causes are still unknown, breast cancer cannot be prevented completely even till now. Microcalcification clusters are primary indicators of malignant types of breast cancer, the detection is important to prevent and treat the disease. The microcalcifications appear in the small clusters of a few pixels with relatively high intensity and closed contours compared with their neighboring pixels. However, it is a challenge to detect all the microcalcifications since they appear as spots which are slightly brighter than their backgrounds. This paper presents an approach for detecting microcalcifications in digital mammograms employing a dual-threshold method. These microcalcifications can be located by our new method which is developed from LoG edge detection method. Two thresholds are proposed in our method based on two additional criterions. Experimental results show that the proposed method can locate the microcalcifications exactly in mammogram as well as restrain the contours produced by the noises. Keywords Digital Mammography Edge Point Closed Contour Digital Mammogram Woman Mortality These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1 January 2006
- Published by Springer Nature
- Vol. 25 (5) , 347-354
Detection of Microcalcifications in Digital Mammograms Based on Dual-Threshold
Breast cancer is one of the main leading causes to women mortality in the world especially in the western countries. Since the causes are still unknown, breast cancer cannot be prevented completely even till now. Microcalcification clusters are primary indicators of malignant types of breast cancer, the detection is important to prevent and treat the disease. The microcalcifications appear in the small clusters of a few pixels with relatively high intensity and closed contours compared with their neighboring pixels. However, it is a challenge to detect all the microcalcifications since they appear as spots which are slightly brighter than their backgrounds. This paper presents an approach for detecting microcalcifications in digital mammograms employing a dual-threshold method. These microcalcifications can be located by our new method which is developed from LoG edge detection method. Two thresholds are proposed in our method based on two additional criterions. Experimental results show that the proposed method can locate the microcalcifications exactly in mammogram as well as restrain the contours produced by the noises. Keywords Digital Mammography Edge Point Closed Contour Digital Mammogram Woman Mortality These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1 June 2004
- Published by Springer Nature in Journal of Intelligent Manufacturing
- Vol. 15 (3) , 373-380
Intelligent condition monitoring using fuzzy inductive learning
- 1 June 2004
- Published by Springer Nature in Journal of Intelligent Manufacturing
- Vol. 15 (3) , 373-380
Intelligent condition monitoring using fuzzy inductive learning